BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28931618)

  • 1. Predicting Major Bleeding in Ischemic Stroke Patients With Atrial Fibrillation.
    Hilkens NA; Algra A; Greving JP
    Stroke; 2017 Nov; 48(11):3142-3144. PubMed ID: 28931618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk scores for major bleeding from direct oral anticoagulants: comparing predictive performance in patients with atrial fibrillation.
    Campos-Staffico AM; Jacoby JP; Dorsch MP; Limdi NA; Barnes GD; Luzum JA
    Res Pract Thromb Haemost; 2024 Jan; 8(1):102285. PubMed ID: 38292348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study.
    Wilson D; Ambler G; Shakeshaft C; Brown MM; Charidimou A; Al-Shahi Salman R; Lip GYH; Cohen H; Banerjee G; Houlden H; White MJ; Yousry TA; Harkness K; Flossmann E; Smyth N; Shaw LJ; Warburton E; Muir KW; Jäger HR; Werring DJ;
    Lancet Neurol; 2018 Jun; 17(6):539-547. PubMed ID: 29778365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and Determinants of Traumatic Intracranial Bleeding Among Older Veterans Receiving Warfarin for Atrial Fibrillation.
    Dodson JA; Petrone A; Gagnon DR; Tinetti ME; Krumholz HM; Gaziano JM
    JAMA Cardiol; 2016 Apr; 1(1):65-72. PubMed ID: 27437657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ISCHEMIC STROKE AND MAJOR BLEEDING WHILE ON DIRECT ORAL ANTICOAGULANTS IN NAÏVE PATIENTS WITH ATRIAL FIBRILLATION: IMPACT OF RESUMPTION OR DISCONTINUATION OF ANTICOAGULANT TREATMENT. A population-based study.
    Gennaro N; Ferroni E; Zorzi M; Denas G; Pengo V
    Int J Cardiol; 2024 Jan; 394():131369. PubMed ID: 37722453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation for atrial fibrillation in patients on dialysis: are the benefits worth the risks?
    Shen JI; Turakhia MP; Winkelmayer WC
    Curr Opin Nephrol Hypertens; 2012 Nov; 21(6):600-6. PubMed ID: 23079746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of anaemia with bleeding and thrombotic complications in patients with atrial fibrillation treated with warfarin: a registry-based nested case-control study.
    Helin TA; Raatikainen P; Lehto M; Haukka J; Lassila R
    BMJ Open; 2023 Nov; 13(11):e071342. PubMed ID: 37918932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke and bleeding risk in atrial fibrillation.
    Senoo K; Lane D; Lip GY
    Korean Circ J; 2014 Sep; 44(5):281-90. PubMed ID: 25278980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral anticoagulant safety in family practice: prognostic accuracy of Bleeding Risk Scores (from the CACAO study).
    Gaboreau Y; Frappé P; Vermorel C; Foote A; Bosson JL; Pernod G;
    Fam Pract; 2024 Feb; 41(1):9-17. PubMed ID: 38281089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Cerebral Microbleeds in Stroke Patients with Atrial Fibrillation.
    Soo Y; Zietz A; Yiu B; Mok VCT; Polymeris AA; Seiffge D; Ambler G; Wilson D; Leung TWH; Tsang SF; Chu W; Abrigo J; Cheng C; Lee KJ; Lim JS; Shiozawa M; Koga M; Chabriat H; Hennerici M; Wong YK; Mak H; Collet R; Inamura S; Yoshifuji K; Arsava EM; Horstmann S; Purrucker J; Lam BYK; Wong A; Kim YD; Song TJ; Lemmens R; Eppinger S; Gattringer T; Uysal E; Demirelli DS; Bornstein NM; Assayag EB; Hallevi H; Molad J; Nishihara M; Tanaka J; Coutts SB; Kappelle LJ; Al-Shahi Salman R; Jager R; Lip GYH; Goeldlin MB; Panos LD; Mas JL; Legrand L; Karayiannis C; Phan T; Bellut M; Chappell F; Makin S; Hayden D; Williams D; van Dam-Nolen DHK; Nederkoorn PJ; Barbato C; Browning S; Wiegertjes K; Tuladhar AM; Mendyk AM; Köhler S; van Oostenburgge R; Zhou Y; Xu C; Hilal S; Gyanwali B; Chen C; Lou M; Staals J; Bordet R; Kandiah N; de Leeuw FE; Simister R; Hendrikse J; Wardlaw J; Kelly P; Fluri F; Srikanth V; Calvet D; Jung S; Kwa VIH; Smith EE; Hara H; Yakushiji Y; Orken DN; Fazekas F; Thijs V; Heo JH; Veltkamp R; Ay H; Imaizumi T; Lau KK; Jouvent E; Toyoda K; Yoshimura S; Bae HJ; Martí-Fàbregas J; Prats-Sánchez L; Lyrer P; Best J; Werring D; Engelter ST; Peters N;
    Ann Neurol; 2023 Jul; 94(1):61-74. PubMed ID: 36928609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early vs late anticoagulation in acute ischemic stroke with indications outside atrial fibrillation.
    Jumah A; Fu S; Albanna AJ; Agarwal U; Fana M; Choudhury O; Idris A; Elfaham A; Iqbal Z; Schultz L; Latack K; Brady M; Scozzari D; Ramadan AR
    J Stroke Cerebrovasc Dis; 2024 Jul; 33(7):107757. PubMed ID: 38705498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of bleeding risk scores in elderly patients with atrial fibrillation and oral anticoagulation.
    Domínguez-Erquicia P; Raposeiras-Roubín S; Abu-Assi E; Lizancos-Castro A; Parada-Barcia JA; González-García A; Ledo-Piñeiro A; Noriega-Caro V; Iglesias-Otero C; Íñiguez-Romo A
    J Geriatr Cardiol; 2023 Sep; 20(9):684-692. PubMed ID: 37840634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemorrhagic transformation following ischaemic stroke: A retrospective study.
    Pande SD; Win MM; Khine AA; Zaw EM; Manoharraj N; Lolong L; Tin AS
    Sci Rep; 2020 Mar; 10(1):5319. PubMed ID: 32210323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restart TICrH: An Adaptive Randomized Trial of Time Intervals to Restart Direct Oral Anticoagulants after Traumatic Intracranial Hemorrhage.
    Milling TJ; Warach S; Johnston SC; Gajewski B; Costantini T; Price M; Wick J; Roward S; Mudaranthakam D; Dula AN; King B; Muddiman A; Lip GYH
    J Neurotrauma; 2021 Jun; 38(13):1791-1798. PubMed ID: 33470152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation in Patients with End-Stage Renal Disease and Atrial Fibrillation: Confusion, Concerns and Consequences.
    Goel N; Jain D; Haddad DB; Shanbhogue D
    J Stroke; 2020 Sep; 22(3):306-316. PubMed ID: 33053946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tailoring anticoagulant treatment of patients with atrial fibrillation using a novel bleeding risk score.
    Chu G; Valerio L; van der Wall SJ; Barco S; Konstantinides S; Huisman MV; Klok FA
    Heart; 2020 Sep; ():. PubMed ID: 32907824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of bleeding complications after transcatheter mitral valve repair.
    Paukovitsch M; Schepperle N; Pott A; Buckert D; Moritz Schneider L; Keßler M; Reichart C; Rottbauer W; Markovic S
    Int J Cardiol Heart Vasc; 2021 Feb; 32():100707. PubMed ID: 33457493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of atrial fibrillation in nursing homes: A place for direct acting oral anticoagulants?
    Alcusky M; Lapane KL
    J Nurs Home Res Sci; 2018; 4():15-19. PubMed ID: 31549021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the Real-World and Clinical Trial Bleeding Rates Associated with Oral Anticoagulation Treatment for Atrial Fibrillation.
    Gue Y; Bloomfield D; Freedholm D; Lip GYH
    J Clin Med; 2024 Apr; 13(8):. PubMed ID: 38673550
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.